(function(){var loadHandler=window['sl_{656BC694-C0A1-4D3A-883A-292145561588}'];loadHandler&&loadHandler(31, '<div id="spr0_3a3ea6f"><div id="spr1_3a3ea6f" class="kern slide"><img id="img0_3a3ea6f" src="data/img15.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_3a3ea6f" class="kern slide"><div id="svg7_3a3ea6f" style="left:679.146px;top:91.323px;"><svg width="8" height="575" viewBox="-0 -0 8 575"><g fill="none"><g transform="translate(3.968994,0)"><g fill="#ff5f05" stroke="none" transform="translate(-3.969012,-0)"><path stroke="#ff5f05" stroke-width="1" stroke-linecap="butt" transform="translate(3.969012,0)" d="M0,7.144 V567.408"/><path transform="matrix(-0,1,-1,-0,3.969025,0)" d="M0,0 L7.938,-3.969 V3.969 Z M574.552,0 L566.614,3.969 V-3.969 Z"/></g></g></g></svg></div><div id="svg15_3a3ea6f" style="left:221.961px;top:359.51px;"><svg width="930" height="8" viewBox="0 -0 930 8"><g fill="none"><g transform="translate(0,3.968994)"><g fill="#ff5f05" stroke="none" transform="translate(0,-3.969)"><path stroke="#ff5f05" stroke-width="1" stroke-linecap="butt" transform="translate(0,3.969)" d="M7.144,0 H922.723"/><path transform="translate(0,3.969)" d="M0,0 L7.938,-3.969 V3.969 Z M929.867,0 L921.929,3.969 V-3.969 Z"/></g></g></g></svg></div><div id="spr3_3a3ea6f" style="left:603.683px;top:38.404px;"><div style="width:0px;"><span id="txt0_3a3ea6f" class="nokern" data-width="135.773438" style="left:22.885px;top:1.235px;">Risk-sharing</span></div></div><div id="spr4_3a3ea6f" style="left:607.516px;top:674.594px;"><div style="width:0px;"><span id="txt1_3a3ea6f" class="nokern" data-width="180.082031" style="left:0.719px;top:1.235px;">Non risk-sharing</span></div></div><div id="spr5_3a3ea6f" style="left:1242.547px;top:287.881px;"><div style="width:0px;"><span id="txt2_3a3ea6f" class="nokern" data-width="166.792969" style="left:7.135px;top:1.235px;">Outcome-based</span></div></div><div id="spr6_3a3ea6f" style="left:114.449px;top:439.078px;"><div style="width:0px;"><span id="txt3_3a3ea6f" class="nokern" data-width="169.019531" style="left:6.135px;top:1.235px;">Financial-based</span></div></div><div id="svg16_3a3ea6f" style="left:271.364px;top:98.216px;"><svg width="383" height="244" viewBox="-0.333 -0.333 383 244"><path fill="#ffffff" stroke="#000000" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.333,0.333 h380.844 v242.439 h-380.844 Z"/></svg></div><div id="spr7_3a3ea6f" style="left:271.698px;top:98.55px;"><div style="width:0px;"><span id="txt4_3a3ea6f" data-width="204.895844" style="left:9.933px;top:4.817px;">Financial-based rebates</span></div><div style="width:0px;"><span id="txt5_3a3ea6f" data-width="142.062500" style="left:9.933px;top:42.617px;">Cost-based MEA</span></div><div style="width:0px;"><span id="txt6_3a3ea6f" data-width="176.125000" style="left:9.933px;top:80.417px;">Discounted list price</span></div><div style="width:0px;"><span id="txt7_3a3ea6f" data-width="297.989594" style="left:9.933px;top:118.217px;">Volume-based/service-based MEA</span></div><div style="width:0px;"><span id="txt8_3a3ea6f" data-width="326.406250" style="left:9.933px;top:156.017px;">Intellectual property-based payments</span></div><div style="width:0px;"><span id="txt9_3a3ea6f" data-width="277.312500" style="left:9.933px;top:193.817px;">Subscription “Netflixlike” model</span></div></div><div id="svg17_3a3ea6f" style="left:700.49px;top:100.509px;"><svg width="434" height="249" viewBox="-0.333 -0.333 434 249"><path fill="#ffffff" stroke="#000000" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.333,0.333 h432.63 v247.184 h-432.63 Z"/></svg></div><div id="spr8_3a3ea6f" style="left:700.823px;top:100.843px;"><div style="width:0px;"><span id="txt10_3a3ea6f" data-width="407.265625" style="left:9.933px;top:3.398px;">Front-load payments: value-based pricing/payment/insurance,</span></div><div style="width:0px;"><span id="txt11_3a3ea6f" data-width="414.093750" style="left:9.933px;top:23.752px;">outcome-based rebates, indication-specific/performance-based</span></div><div style="width:0px;"><span id="txt12_3a3ea6f" data-width="44.031250" style="left:9.933px;top:46.105px;">pricing</span></div><div style="width:0px;"><span id="txt13_3a3ea6f" data-width="386.859375" style="left:9.933px;top:75.125px;">Back-load payments: coverage with evidence development,</span></div><div style="width:0px;"><span id="txt14_3a3ea6f" data-width="414.070313" style="left:9.933px;top:95.478px;">annuity: milestone/performance-based, in instalments, capped,</span></div><div style="width:0px;"><span id="txt15_3a3ea6f" data-width="362.773438" style="left:9.933px;top:115.832px;">ORBM and risk pooling, performance-based risk-sharing</span></div><div style="width:0px;"><span id="txt16_3a3ea6f" data-width="403.617188" style="left:9.933px;top:136.185px;">agreement (PBRSA), outcome-based MEA, technology-specific</span></div><div style="width:0px;"><span id="txt17_3a3ea6f" data-width="134.335938" style="left:9.933px;top:158.538px;">coverage framework</span></div><div style="width:0px;"><span id="txt18_3a3ea6f" class="relpos" data-width="203.648438" style="left:9.933px;top:189.558px;">Accountable care organisations</span> <span id="txt19_3a3ea6f" class="relpos" data-width="8.000000" style="left:9.927px;top:191.961px;">, </span> <span id="txt20_3a3ea6f" class="relpos" data-width="202.742188" style="left:9.92px;top:189.558px;">Patient centred medical homes</span></div><div style="width:0px;"><span id="txt21_3a3ea6f" data-width="140.210938" style="left:9.933px;top:217.858px;">Oncology Care Model</span></div></div><div id="svg18_3a3ea6f" style="left:271.365px;top:383.702px;"><svg width="383" height="291" viewBox="-0.333 -0.333 383 291"><path fill="#ffffff" stroke="#000000" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.333,0.333 h380.844 v289.067 h-380.844 Z"/></svg></div><div id="spr9_3a3ea6f" style="left:271.698px;top:384.035px;"><div style="width:0px;"><span id="txt22_3a3ea6f" data-width="253.914047" style="left:9.933px;top:5.11px;">Fee/tariff based/add-on payment</span></div><div style="width:0px;"><span id="txt23_3a3ea6f" data-width="170.296875" style="left:9.933px;top:39.523px;">Higher weighted DRGs</span></div><div style="width:0px;"><span id="txt24_3a3ea6f" data-width="96.842445" style="left:9.933px;top:73.937px;">Health funds</span></div><div style="width:0px;"><span id="txt25_3a3ea6f" data-width="265.589844" style="left:9.933px;top:108.35px;">Direct to consumer (out-of-pocket)</span></div><div style="width:0px;"><span id="txt26_3a3ea6f" data-width="134.631500" style="left:9.933px;top:142.763px;">Bundled payment</span></div><div style="width:0px;"><span id="txt27_3a3ea6f" data-width="354.347656" style="left:9.933px;top:175.177px;">American Society of Clinical Oncology’s Clinical</span></div><div style="width:0px;"><span id="txt28_3a3ea6f" data-width="247.351547" style="left:9.933px;top:200.923px;">Practice Committee (CPC) model</span></div><div style="width:0px;"><span id="txt29_3a3ea6f" data-width="131.569000" style="left:9.933px;top:235.337px;">Upfront payment</span></div><div style="width:0px;"><span id="txt30_3a3ea6f" style="left:9.933px;top:266.905px;"> </span></div></div><div id="svg19_3a3ea6f" style="left:151.555px;top:365.304px;"><svg width="318" height="254" viewBox="-99.318 -57.389 318 254"><g fill="none"><path fill="#ff5f05" d="M0,126.918 L24.28,100.815 V112.955 A97.12,57.389 0 0,0 94.923,69.529 A97.12,57.389 0 0,1 24.28,137.236 V149.376 Z"/><path fill="#cd4c04" d="M0,0 A97.12,57.389 0 0,1 97.12,57.389 V81.669 A97.12,57.389 0 0,0 0,24.28 Z"/><path d="M97.12,81.669 A97.12,57.389 0 0,0 0,24.28 V0 A97.12,57.389 0 0,1 97.12,57.389 V81.669 A97.12,57.389 0 0,1 24.28,137.236 V149.376 L0,126.918 L24.28,100.815 V112.955 A97.12,57.389 0 0,0 94.923,69.529"/></g></svg></div><div id="spr10_3a3ea6f" style="left:788.953px;top:378.37px;"><div style="width:0px;"><span id="txt31_3a3ea6f" class="nokern relpos" dir="auto" style="left:9.6px;top:5.924px;">•</span> <span id="txt32_3a3ea6f" class="relpos" data-width="262.136719" style="left:31.198px;top:6.035px;">Reimbursement package</span></div><div style="width:0px;"><span id="txt33_3a3ea6f" data-width="292.394531" style="left:39.6px;top:34.835px;">(test+treatment), dedicated</span></div><div style="width:0px;"><span id="txt34_3a3ea6f" data-width="150.656250" style="left:39.6px;top:63.635px;">codes for tests</span></div><div style="width:0px;"><span id="txt35_3a3ea6f" class="nokern relpos" dir="auto" style="left:9.6px;top:92.324px;">•</span> <span id="txt36_3a3ea6f" class="relpos" data-width="289.312500" style="left:31.198px;top:92.435px;">Performance-based models</span></div><div style="width:0px;"><span id="txt37_3a3ea6f" class="nokern relpos" dir="auto" style="left:9.6px;top:121.124px;">•</span> <span id="txt38_3a3ea6f" class="relpos" data-width="248.789063" style="left:31.198px;top:121.235px;">Coverage with evidence</span></div><div style="width:0px;"><span id="txt39_3a3ea6f" data-width="137.625000" style="left:39.6px;top:150.035px;">development</span></div></div></div></div>', '{"s":[]}');})();